Literature DB >> 2913924

Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds.

T D Bird1, S M Sumi, E J Nemens, D Nochlin, G Schellenberg, T H Lampe, A Sadovnick, H Chui, G W Miner, J Tinklenberg.   

Abstract

We report the clinical and neuropathological characteristics occurring in 180 demented individuals from 24 kindreds with familial Alzheimer's disease (FAD). Each family had at least two affected generations, and at least one autopsy or brain biopsy was compatible with the diagnosis of AD. Forty-nine neuropathological specimens or reports were reviewed. Mean age of onset for the total group was 54.7 years +/- 11.5, with a large range of 30 to 84 years. Mean age at death was 63.5 years +/- 12.2, with a range of 46 to 85. Mean duration of disease was 8.8 years +/- 4.4, with a range of 1 to 23 years. Six findings suggested phenotypic heterogeneity in FAD. (1) Five families represented an early age of onset group with mean onset at 42 years (range 30 to 51 years) and mean disease duration of 6.7 years. (2) Eight families represented a late onset group with mean onset at 68 years (range 59 to 78 years) and a mean duration of 8.5 years. (3) Seven families were of Volga German ancestry, all originating from the same two villages in Russia. Mean age of onset was 55.9 years (range 40 to 72 years), with a mean disease duration of 10 years. This group probably represents the genetic founder effect of an autosomal dominant gene for AD. (4) One family had the unusual characteristics of neurofibrillary tangles and granulovacuolar change but no amyloid plaques, a mean disease duration of more than 11 years, and a "schizophrenia-like" onset. (5) One family with late onset also had clinical and pathological evidence for anterior horn cell disease. (6) Two autopsies in 1 family both showed remarkable rarefaction of myelin and expansion of perivascular spaces in centrum semiovale (état criblé), with marked leptomeningeal and cortical amyloid angiopathy, distinct from the other FAD brains. It remains to be determined whether the clinical and pathological differences between these families represent genetic heterogeneity at the biochemical or molecular level.

Entities:  

Mesh:

Year:  1989        PMID: 2913924     DOI: 10.1002/ana.410250104

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   11.274


  19 in total

1.  Neuropsychological function in nondemented carriers of presenilin-1 mutations.

Authors:  J M Ringman; C Diaz-Olavarrieta; Y Rodriguez; M Chavez; L Fairbanks; F Paz; A Varpetian; H C Maldonado; M A Macias-Islas; J Murrell; B Ghetti; C Kawas
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

2.  RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion.

Authors:  Amar Kar; Necat Havlioglu; Woan-Yuh Tarn; Jane Y Wu
Journal:  J Biol Chem       Date:  2006-06-15       Impact factor: 5.157

3.  Molecular pathology of Alzheimer's disease.

Authors:  M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

4.  Finding noncommunicating sets for Markov chain Monte Carlo estimations on pedigrees.

Authors:  S Lin; E Thompson; E Wijsman
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

5.  The identification of pathological subtypes of Alzheimer's disease using cluster analysis.

Authors:  R A Armstrong; L Wood
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Genetic counseling throughout the life cycle.

Authors:  Leslie J Ciarleglio; Robin L Bennett; Jennifer Williamson; Jessica B Mandell; Joan H Marks
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

7.  Genetics and genetic counseling: recommendations for Alzheimer's disease, frontotemporal dementia, and Creutzfeldt-Jakob disease.

Authors:  Jennifer Williamson; Susan LaRusse
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

8.  Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2.

Authors:  Ellen M Wijsman; E Warwick Daw; Change-En Yu; Haydeh Payami; Ellen J Steinbart; David Nochlin; Erin M Conlon; Thomas D Bird; Gerard D Schellenberg
Journal:  Am J Hum Genet       Date:  2004-07-08       Impact factor: 11.025

9.  Chromosome 14 and late-onset familial Alzheimer disease (FAD).

Authors:  G D Schellenberg; H Payami; E M Wijsman; H T Orr; K A Goddard; L Anderson; E Nemens; J A White; M E Alonso; M J Ball
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

10.  Clinical diagnosis of Binswanger's disease.

Authors:  D A Bennett; R S Wilson; D W Gilley; J H Fox
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.